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Abstract: 
Objective: To assess the prevalence and identify markers of malnutrition in outpatients with chronic heart failure (CHF). 
Materials and methods: At the first stage, the prevalence of malnutrition in patients with CHF who were on an outpatient admission 
was determined. 
Patients were randomly included in the study, regardless of the presence of signs of malnutrition. An individual questionnaire with 
anthropometric parameters was filled in for each included patient. 
Patients with CHF who have a body mass index (BMI) of less than 20 kg / m2 were included in the second phase of the study. The 
trophological status was assessed using anthropometric, clinical, and laboratory methods, and the nutritional risk index (NRI) was 
investigated. 
Results: A decrease in nutritional status was observed in 63.1% of outpatients with cachexia and CHF I-III Functional Class (from 
all patients suffering from low body weight), and was characterized by a decrease in lean body mass (LBM) / Body Fat Mass (BFM) 
ratio, low absolute lymphocyte count, serum albumin, and nutritional risk index (NRI). 
The assessment of the trophological status in patients with CHF was carried out not only by BMI, but also by calculating the main 
components of body weight – Lean Body Mass and Body Fat Mass on the basis of measurements of skin and fat folds. 
Conclusion: The weight deficit among outpatients made up 8% of the population, while 5% (53 patients) had CHF. Body mass 
index and serum albumin are currently the most commonly used indicators for clinical nutritional assessment in outpatient practice. 
However, the method of assessing malnutrition by the nutritional risk index is more reliable, easier to use, and makes it possible 
to reliably estimate the nutritional status in patients with CHF. 
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INTRODUCTION: 
For 16 years in the Russian Federation, the prevalence 
of chronic heart failure (CHF) increased significantly 
from 4.9% to 10.2%. At the same time, the number of 
patients with chronic heart failure III-IV Functional 
Class increased significantly: from 1.2% to 4.1%.  
 
The overall mortality of patients with CHF is 6% per 
year [1]. The problem of the prevention of 
decompensation and the creation of a basis for a stable 
course of CHF is one of the main tasks of the 
cardiological medical community, which makes it 
necessary to consider this area as a priority in medicine 
[2, 3, 4]. 
 
Patients with chronic heart failure in some cases 
develop cachexia, especially in severe disease. Early 
studies have shown that a decrease in body mass index 
(BMI) shortens life expectancy [5, 6, 7]. 
 
In patients with chronic heart failure, there is an 
inverse relationship between BMI and mortality, 
which is sometimes called the obesity paradox. These 
results were obtained in a large-scale study of 
MAGGIC (n = 53,210) [7]. 
 
A meta-analysis of four more studies, including 59 263 
patients, also confirms that there is a paradox of 
obesity in patients with chronic heart failure [5, 8, 9, 
10]. 
 
At the same time, the relationship may be either U- or 
J-shaped and may be different between patients with a 
low ejection fraction (HF-rEF, EF <40%) and 
preserved left-ventricular EF (HF-pEF, EF ≥50%) [5 
]. 
 
Revealed the relationship between a moderate increase 
in BMI and prolongation of life expectancy. With very 
low body weight and significant obesity, mortality is 
increasing. The meta-analysis by Zhang J. et al. (2018) 
confirms a narrow minimum risk range for both HF-
rEF and HF-pEF, with a BMI of 32-33 kg / m2, 
although the U-shaped ratio is more “flat” for HF- rEF 
[5]. 
 
A number of studies indicate the paradox of obesity in 
patients over the age of 50 years with established 
cardio-metabolic disease [11]. This was found in 
hypertension [12], type 2 diabetes [13, 14], atrial 
fibrillation [15, 16] and coronary heart disease [17], as 
well as in heart failure [18, 19]. 
 
The ESC guidelines for heart failure (2016) no longer 
recommend weight loss in moderate obesity patients 
[20]. The clinical recommendations for CHF (2017) 
indicate that in cardiac cachexia and low body weight 
(with an initial BMI of less than 19 kg/m2), or with a 
loss of body weight by 5 kg or more, or more than 
7.5% of the initial mass in a compensated state for six 
months, it is necessary to combine medical correction 
of neurohormonal disorders with nutritional support 
and cytokine blockade [21].  
 
The cachexia in patients with CHF develops within the 
framework of the chronic inflammatory syndrome [22] 
and has an unfavourable prognosis regardless of the 
severity of the disease, the patient's age, exercise 
tolerance and indices of contractility of the left 
ventricular myocardium [23]. 
 
According to the literature, it is obvious that the use of 
any one anthropometric or laboratory indicator will 
not be an objective reflection of the nutritional status 
of the patient. In addition, in practical activities with a 
known temporary limit, the doctor needs the 
possibility of a quick and preferably simple 
assessment of nutritional status. 
 
In this regard, integral assessment systems began to be 
actively introduced into clinical practice, allowing a 
combination of several parameters to determine the 
QR code 
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current nutritional status of the patient. The American 
Nutrition Society (ASPEN) recommends for these 
purposes the Patient Generated Subjective Global 
Assessment (PGSGA, more often simply SGA) 
questionnaire. SGA parameters include evaluating 
patient weight loss, dietary restriction, signs of 
dyspeptic disorders, functional activity, and a number 
of anthropometric and clinical indicators. 
 
Determination of nutritional status on the scale of 
"nutritive risk Assessment" (Nutritional Risk 
Screening (NRS) 2002 is based on the gradual 
exclusion from the entire population of patients 
without trophic disorders. At the first stage (initial 
assessment), patients are screened for only three 
parameters. 
If there is a positive result in the initial assessment, 
then we should proceed to the second evaluation 
block. The age-related nutritional risk index (Geriatric 
Nutritional Risk Index) is one of the most commonly 
used indicators in the elderly population. One of the 
easiest to use and fairly objective evaluation scale is 
the index of Nutritional Risk Index (NRI), which takes 
into account plasma albumin and body weight [24]. 
The question is : what is the best system for assessing 
nutritional status?  
 
Based on the evaluation of the literature data, it should 
be noted that today there are several systems for 
assessing nutritional status in the mono version or 
combined, which is quite acceptable for research. 
However, for clinical practice there are no reliable, 
reasoned, easy-to-use and statistically reliable markers 
of identification of malnutrition in adults. 
 
Aim 
The aim of this article was to assess the prevalence and 
identify reliable markers of diagnosis of malnutrition 
in outpatients with chronic heart failure. 
Investigation task:  
1.Analysis of the prevalence of malnutrition in 
outpatients with CHF. 
2.Isolation and detection of markers of malnutrition 
syndrome in outpatients with chronic heart failure. 
 
MATERIALS AND METHODS: 
At the first stage, to determine the prevalence of 
malnutrition, a study of 1050 patients was conducted. 
Primary care physicians and cardiologists from 
February to may of 2018, visited polyclinic №8 of the 
city of Belgorod. Patients were randomly included in 
the study, regardless of the presence of signs of 
malnutrition. An individual questionnaire with 
anthropometric parameters was filled in for each 
included patient. The exclusion criteria was the 
presence of malignant neoplasm, liver cirrhosis, 
systemic connective tissue diseases. 84 patients with 
BMI less than 20 kg/m2 were identified from this 
cohort, among them 53 patients had CHF. 
 
The second stage of the study included all 53 patients 
with CHF with BMI less than 20 kg / m2. 
Trophological status was assessed using 
anthropometric and laboratory methods. In addition, 
age, sex, functional class (FC) of CHF according to 
NYHA, blood pressure level and concomitant 
pathology were taken into account, exercise tolerance 
was assessed according to the results of a 6-minute 
test, EF according to echocardiography [25]. While 
collecting anamnesis in patients, the level of daily 
physical activity was clarified, how quickly their 
weight decreased, whether the diet and doctor's 
recommendations were followed, and awareness of the 
disease. 
 
Laboratory parameters included a study of the total 
blood count, which evaluated the absolute number of 
lymphocytes, biochemical parameters: albumin, total 
protein, fasting blood glucose, cholesterol spectrum, 
potassium, sodium and serum creatinine. The degree 
of malnutrition according to laboratory criteria was 
assessed in table 1. 
 
Table 1:Laboratory criteria for malnutrition 
Indicator Normal value Degree of malnutrition 
I II III 
Albumin, g/l >35 35-30 30-25 <25 
Lymphocytes, 106/l >1800 1800-1500 1500-900 <900 
It should be noticed that dehydration increases the 
concentration of proteins and hyperhydration – 
reduces. 
Anthropometric parameters were estimated: height 
(cm), weight (kg), thickness of the skin-fat fold. The 
ideal body mass index was also calculated. 
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BMI = m / h2, where m is weight in kg, h is height in 
meters. 
 
In accordance with who recommendations, age-
appropriate BMI indicators were interpreted as 
follows. 
 
       Reduced power: BMI-19,0-19,9. 
       Malnutrition I degree: BMI-17.5-18.9. 
       Malnutrition II degree: BMI is 15.5 and 17.4. 
       Malnutrition III degree: BMI below 15.5. 
       Determination of lean body mass (LBM) and body 
fat mass (LMC) was carried out by method of 
durnin –Womersley. This made the calculation of 
the thickness of the skin and fat of the amount of 
folds (BHC), after getting measurement for 4 
standard points (mm), calculation of logarithm 
(log), amount (S) BHC, the density of the body (L 
g/ml) according to the following formulas: 
 
For men >50 years D = 1,1715-0,0779 x (magazines)  
 
For women>50 years D = 1,1339-0,0645 x 
(magazines), 
 
The thickness of the skin fold (CSF) was determined 
at the level of the lower angle of the shoulder blade, in 
the paraumbilical region on the side of the rectus 
abdominis, at the level of the middle third of the 
shoulder above the biceps and above the triceps in 
millimeters (mm) with the help of a caliper. The sum 
of the thickness of all 4 skinfolds was calculated and 
the table was used to determine the body fat mass [26]. 
Lean body mass was calculated by subtracting body fat 
mass from the total body mass : 
 
Lean body mass = Total body mass –Body fat 
mass. 
 
Lean body mass was evaluated in comparison 
with due Lean body mass, which was conditionally 
taken equal to 70% or more of the recommended body 
weight (RMT).  
 
To calculate the Recommended body mass, it 
is most appropriate to use the formulas proposed by 
the European Association of nutritionists:  
 
Male Recommended body mass = P-100 - [(P 
– 152) × 0.2] 
 
Women's Recommended body mass = P-100 
- [(P – 152) × 0.4] 
 
Where P is the height of a person in cm. 
The calculation of the nutritive risk index 
(NRI) was calculated by the formula: 
 
NRI =1.519×plasma albumin 
(g/l)+0.417×(body weight 1 (kg) / body weight 2 (kg) 
×100)  
where body weight 1-body weight at the time 
of examination, body weight 2-normal body weight. 
Nutritional status of patients was classified 
as: 
• nutritional insufficiency (NRI>97,5); 
• moderate malnutrition (97,5>NRI>83,5); 
* severe nutritional deficiency (NRI<83.5) 
[24]. 
Statistical analysis of the data was carried out on a 
personal computer using the program "Statistica 6.0" 
and spreadsheets "Microsoft Excel" with the definition 
of averages and correlation. 
 
RESULTS AND THEIR DISCUSSION: 
Among 1050 outpatients who were examined by 
therapists and cardiologist of polyclinic no.8 in 
Belgorod, signs of malnutrition were observed in 8% 
(84 people) of patients, 5% (53 people) had CHF. Of 
these, 63.1% (53 people) were patients with CHF. This 
is below the average incidence of cachexia syndrome, 
which ranges from 13.3% to 16% according to the 
literature [27, 28]. The study "Saturn" studied the 
prevalence of malnutrition in therapeutic patients who 
are on inpatient treatment in therapeutic departments 
or turned to the district therapist. The study showed a 
high prevalence of malnutrition among patients who 
turned to the therapist: 53.2% of patients had signs of 
hypotrophy. Of these, 61% were patients with CHF. 
The nutritional status of patients with CHF depends on 
the duration of the disease and the adequacy of drug 
therapy [29]. The difference between the results may 
be due to the fact that more severe (decompensated) 
patients receive treatment at home or in a hospital, and 
more safe patients come to the clinic. 
 
It was revealed that the average age of patients with 
CHF was 69 years, with the average age of women - 
71.1 ± 5.8 years, men - 68.2 ± 4.6 years. Literature data 
indicate an increase in malnutrition with age.  
 
Malnutrition in our study was in 58.5% of men (n=31) 
and 41.5% (n=22) of women. Thus, malnutrition is 
significantly more common in males in the outpatient 
fraction. 
Distribution of patients in the Functional 
Class of CHF was the following: I – 4 (7,5%), II – 28 
(53%), III – 21 (39,5%).  
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Signs of malnutrition on BMI: I degree-26 patients 
(49.1%), II degree – 16 (30.2%), III degree – 5 (9.4%). 
Reduced nutrition was found in 6 (11.3%). The 
average BMI among men was 16.9 kg / m2, in women-
17.4 kg / m2. 
 
In a number of studies, it is proved that with decline of 
lean body mass, muscle dysfunction and shortness of 
breath are seen [30, 31]. However, according to N. 
Vorobyov. (2009), in everyday practice, Lean body 
mass reduction remains unnoticed for a long time due 
to the pronounced fat deposits and the lack of 
evaluation standards [30]. When assessing 
malnutrition by anthropometric parameters, the 
proportion of patients with moderate or severe 
malnutrition was 29%, and, accordingly, 61% with 
mild malnutrition. At the same time, women had 
significantly less Lean body mass than men (p<0.01). 
In the study of SATURN II, the increase in Lean body 
mass naturally manifested itself in an increase in 
exercise tolerance, which was confirmed by the results 
of a 6-minute test, while there was a decrease in 
functional Class of CHF in patients with nutritional 
support [31]. 
 
When calculating and evaluating the nutritional risk 
index (NRI), the average was NRI - 91. At the same 
time, a correlation of low NRI results with older age, 
lower body mass index, higher CHF Fuctional Class, 
concomitant atrial fibrillation, anemia and reduced 
mobility was more observed.  
 
Our study revealed a moderate correlation between 
malnutrition (when calculating NRI) and exercise 
tolerance (according to the 6-minute test) (r = 0.42; 
p<0.05); NRI and Functional Class of CHF (r = -0.4; 
p<0.05). Our data are consistent with the study of 
Skhirtladze M. R., Drapkina O. M. (2011), which 
revealed a correlation between the state of trophic 
status and the most important characteristics of heart 
function in patients with CHF [32]. 
 
In 21 (39.6%) patients there were only anthropometric 
criteria for malnutrition, in 13 (24.5%) - only 
laboratory ones, 19 (35.9%) - had both laboratory and 
anthropometric signs of malnutrition. The complexity 
of biochemical processes in the pathophysiology of 
CHF and cachexia suggests that one marker may not 
reflect all the features of the disease. Taking into 
account this limitation, future research should focus on 
the development and use of an optimal combination of 
several markers that better reflects all the features of 
the syndrome. 
 
CONCLUSION: 
1. Weight deficit among outpatients was 8% of the 
population, while 5% (53 people) of patients had CHF. 
2. Decrease in nutritional status was observed in 
63.1% of outpatients with cachexia and CHF I-III of 
Functional Class (all patients with low body weight), 
and was characterized by a decrease in the ratio of 
Lean body mass/BMI, low levels of absolute number 
of lymphocytes, serum albumin and nutritional risk 
index (NRI). 
3. Evaluation of trophic status in patients with CHF 
should be carried out not only by BMI, but also by 
calculating the main components of body weight-lean 
body mass and BMI on the basis of measurements of 
skin-fat folds. 
4. Mandatory parameters include anthropometric, 
clinical and laboratory data. These parameters can and 
should be used by a doctor of any specialty to 
determine the current nutritional status. 
5. Body mass index and serum albumin levels are 
currently the most commonly used indicators for 
clinical evaluation of nutrition in outpatient practice. 
Nevertheless, the method of assessment of 
malnutrition on the index of nutritional risk is more 
reliable, easy to use and makes it possible to reliably 
assess the nutritional status in patients with CHF. 
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